Regulatory Considerations for Fecal Microbiota Transplantation Products
- 1 February 2020
- journal article
- editorial
- Published by Elsevier in Cell Host & Microbe
- Vol. 27 (2) , 173-175
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Bacterial viability in faecal transplants: Which bacteria survive?EBioMedicine, 2019
- Alterations in the Abundance and Co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Colonic Mucosa of Inflammatory Bowel Disease SubjectsFrontiers in Cellular and Infection Microbiology, 2018
- Profiling Living Bacteria Informs Preparation of Fecal Microbiota TransplantationsPLOS ONE, 2017
- The gut microbiota of siblings offers insights into microbial pathogenesis of inflammatory bowel diseaseGut Microbes, 2017
- Association betweenFaecalibacterium prausnitziiReduction and Inflammatory Bowel Disease: A Meta-Analysis and Systematic Review of the LiteratureGastroenterology Research and Practice, 2014
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patientsProceedings of the National Academy of Sciences, 2008
- Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov.International Journal of Systematic and Evolutionary Microbiology, 2002